IL13RA2 is highly expressed by brain- and lung-seeking breast cancer cell lines [14, 15] and is often reported to be pro-tumorigenic, pro-metastatic, and correlated with poor patient survival [16–22]. Here, IL13RA2 is linked to breast carcinoma.